The association between current Helicobacter pylori infection and coronary artery disease

Seung-Won Jin1, Sung-Ho Her, Jong-Min Lee

  • 1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul Korea.

Insights

Helicobacter pylori (H. pylori) infection shows a modest influence on coronary artery disease (CAD) and progressive atheroma. Further research is needed to fully understand the H. pylori and CAD relationship.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • The association between Helicobacter pylori (H. pylori) infection and coronary artery disease (CAD) remains controversial.
  • Previous studies have not fully examined the link between current H. pylori infection and CAD pathogenesis.
  • This study investigates the relationship between H. pylori infection, confirmed via biopsy, and the presence of CAD.

Purpose of the Study:

  • To evaluate the association between H. pylori infection and coronary artery disease (CAD).
  • To determine if H. pylori infection influences the progression of atheroma in CAD patients.

Main Methods:

  • Gastroduodenoscopic biopsy was used to detect H. pylori infection in 88 normal coronary angiogram patients and 175 CAD patients.
  • Tissue samples were stained using Warthin-starry silver stain to identify H. pylori.
  • Patients with a history of H. pylori eradication or malignancy were excluded.

Main Results:

  • H. pylori infection was present in 30.7% of the control group and 40.6% of the CAD group, with no statistically significant difference.
  • No significant difference in reintervention rates was observed between H. pylori positive and negative CAD patients undergoing percutaneous coronary intervention (PCI).
  • Demographic and laboratory characteristics were similar between groups, except for gender, age, smoking, and HDL-c levels.

Conclusions:

  • H. pylori infection appears to have a modest influence on CAD and progressive atheroma.
  • A tendency for increased risk was observed, but not statistically significant.
  • Further research is required to elucidate the complex relationship between H. pylori infection and CAD.
Abstract

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...